Severe vital depression as the presenting feature of cyclosporin-A-associated thrombotic microangiopathy.
نویسندگان
چکیده
were positive for Haemophilus influenzae. Renal ultraIntroduction sound showed no abnormalities. A renal biopsy showed Thrombotic microangiopathy (TMA) is a known a borderline interstitial rejection according to the Banff complication associated with cyclosporin A (CsA) classification. CsA trough levels were in the therapeutic therapy after renal transplantation, even in patients who range (150–200 mg/l ). The patient was again treated with do not have haemolytic uraemic syndrome (HUS) as 6×1 g methylprednisolone i.v., but renal function their original renal disease [1]. Manifestations caused by improved only marginally and did not return to baseline. the endothelial swelling and microvascular thrombi Two weeks after this treatment, the patient developed a include renal failure and neurological symptoms such as severe vital depression with lethargy, anorexia and sleepheadache, confusion, seizures and coma [2,3]. lessness. No focal neurological abnormalities were found. Psychiatric manifestations in the form of severe vital Laboratory investigation showed progressive anaemia depression have not been reported until now. We with a decrease in haemoglobin level from 7.2 to describe two patients with CsA-associated TMA 5.5 mmol/l, thrombocytopenia (50×109/l ), and rising several weeks after transplantation in whom the clinical LDH level (1441 U/l ) (Figure 1). In addition, abundant picture was dominated by a severe vital depression schistocytes were found on peripheral blood smear, the without other neurological findings as the sole sign of haptoglobin level was low (<0.1 g/l ) and coagulation possible cerebral localization. tests were normal. A diagnosis of TMA probably related to CsA was made. Cyclosporin A therapy was discontinued and Case 1 plasmapheresis instituted. During this treatment, the microangiopathic blood changes disappeared rapidly A 54-year-old woman with renal failure caused by chronic and there was a dramatic improvement of the vital pyelonephritis and treated with CAPD since May 1994 depression. Also, renal function improved with a underwent a cadaveric kidney transplantation in decrease of the serum creatinine-level to 145 mmol/l. December 1996. Immunosuppression consisted of CsA Immunosuppression was maintained with mycophenol(NeoralA, Novartis), mycophenolate mofetil and lowate mofetil and prednisolone. No recurrent episodes dose prednisolone. Renal graft function was good iniof depression of TMA have occurred since. Current tially, but a biopsy-proven interstitial rejection Banff graft function is excellent with a serum creatinine of grade I was diagnosed on day 20. After failure to respond 105 mmol/l and a creatinine clearance of 65 ml/min. to 6×1 g i.v. methylprednisolone, treatment with rabbit antithymocyte immunoglobulin with temporary discontinuation of CsA according to our local protocol was Case 2 instituted. Graft function improved to baseline-level and the patient was discharged in good clinical condition with A 63-year-old woman received a cadaveric kidney a creatinine clearance of 50 ml/min. transplant in February 1997. Renal failure from medulTwo months later she was readmitted with bronchitis lary polycystic disease and hypertension had led to the and sinusitis with fever up to 39°C. The serum creatinine initiation of CAPD treatment in November 1994, level had risen from 130 to 265 mmol/l. The maxillary which was changed to haemodialysis in May 1996. sinuses were drained and therapy with amoxycillin/clavulImmunosuppression consisted of CsA (NeoralA, anic acid was instituted. Sputum and sinus-fluid cultures Novartis) and low-dose prednisolone. Delayed graft function necessitating haemodialysis treatment Correspondence and offprint requests to: C. A. Stegeman MD PhD, occurred. While still oliguric a Banff grade I interstitial Department of Internal Medicine/Division of Nephrology University rejection was diagnosed by renal biopsy on the 10th Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. post-operative day. Since there was no response to
منابع مشابه
Cyclosporin-associated thrombotic microangiopathy: successful retreatment with cyclosporin.
This report describes a patient who developed cyclosporin-induced thrombotic microangiopathy in a renal allograft. Cyclosporin-induced thrombotic microangiopathy is considered by many as a contraindication to subsequent therapy with cyclosporin. This case is notable for successful treatment with cyclosporin following resolution of thrombotic microangiopathy in a renal allograft.
متن کاملUnusual Case Report of Thrombotic Microangiopathy of the Small Bowel Following Liver Transplantation, a Possible Immunosuppressant-Induced Disease with Histological and Ultrastructural Findings
Cyclosporin-A (CsA) and tacrolimus (FK-506) are immunomodulating agents used to prevent rejection in organ transplantation. They are both associated with several side effects, including nephrotoxicity and severe hypertension due to vascular injury, which often appears as a microvascular occlusive disorder (thrombotic microangiopathy, TMA). We report the first case of a microvascular occlusive d...
متن کاملAssociation between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.
The thrombotic microangiopathy observed in malignant hypertension is similar to that of thrombotic thrombocytopenic purpura, which is associated with a deficiency of ADAMTS13, a von Willebrand factor (VWF)-cleaving protease that cleaves large prothrombogenic multimers. We hypothesized that ADAMTS13 is deficient in malignant hypertension and that the severity of thrombotic microangiopathy is ass...
متن کاملThe Overview of Diagnostic Criteria and Treatment Options of Transplantation Associated Thrombotic Microangiopathy with Two Case Reports
Transplantation associated thrombotic microangiopathy has been considered to be a severe complication of hematopoietic stem cell transplantation. Although there has been an agreement in terms of transplantation associated thrombotic microangiopathy criteria, treatment options has not been clarified yet. Therefore we want to present two patients aged 5 years and 13 years who developed transplant...
متن کاملHaemolytic uraemic syndrome following bone marrow transplantation. Case report and review of the literature.
Thrombotic microangiopathy (TMA) can be a late complication of bone marrow transplantation (BMT). A patient is described in whom the haemolytic uraemic syndrome developed 10 months after BMT and who died of E. coli sepsis while on maintenance haemodialysis. The literature is reviewed, regarding clinical presentation, incidence, pathogenesis and therapy. TMA can be observed, after an interval of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
دوره 14 4 شماره
صفحات -
تاریخ انتشار 1999